• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实际临床实践中肠道白塞病患者贫血的被忽视的管理与风险因素

Overlooked Management and Risk Factors for Anemia in Patients with Intestinal Behçet's Disease in Actual Clinical Practice.

作者信息

Kim Bun, Park Soo Jung, Hong Sung Pil, Cheon Jae Hee, Kim Tae Il, Kim Won Ho

机构信息

Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.

出版信息

Gut Liver. 2015 Nov 23;9(6):750-5. doi: 10.5009/gnl14193.

DOI:10.5009/gnl14193
PMID:25963076
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4625704/
Abstract

BACKGROUND/AIMS: Anemia in patients with inflammatory bowel disease significantly affects the quality of life. The aim of this study was to investigate the frequency of and risk factors for anemia and to describe the management of anemia in patients with intestinal Behçet's disease (BD) in actual clinical practice.

METHODS

We included 64 patients with intestinal BD who visited the outpatient clinic of a tertiary referral center in June 2011 and had available laboratory data for the subsequent 6 months.

RESULTS

Anemia was detected in 26 patients (40.6%). After 6 months, anemia was still present in 14 of these patients (53.8%). The cause of anemia was investigated in eight patients (30.8%), and oral iron supplementation was prescribed to four patients (15.4%). Of these four patients, two (50%) recovered completely within 6 months. Anemia was associated with a high Disease Activity Index for Intestinal Behçet's Disease (DAIBD, p=0.024), erythrocyte sedimentation rate (p=0.003), and C-reactive protein (p=0.049) in univariate analysis. In multivariate analysis, the factor predictive for anemia in patients with intestinal BD was a higher DAIBD (≥40; odds ratio, 4.08; 95% confidence interval, 1.21 to 13.71; p=0.023).

CONCLUSIONS

Although anemia is common in intestinal BD patients, its clinical importance is overlooked in daily practice. Moderate to severe disease activity is predictive of anemia.

摘要

背景/目的:炎症性肠病患者的贫血显著影响生活质量。本研究旨在调查肠道白塞病(BD)患者贫血的发生率和危险因素,并描述实际临床实践中肠道白塞病患者贫血的管理情况。

方法

我们纳入了2011年6月就诊于一家三级转诊中心门诊且在随后6个月有可用实验室数据的64例肠道BD患者。

结果

26例患者(40.6%)检测到贫血。6个月后,其中14例患者(53.8%)仍存在贫血。对8例患者(30.8%)的贫血原因进行了调查,4例患者(15.4%)接受了口服铁剂补充治疗。在这4例患者中,2例(50%)在6个月内完全康复。单因素分析显示,贫血与肠道白塞病疾病活动指数(DAIBD,p=0.024)、红细胞沉降率(p=0.003)和C反应蛋白(p=0.049)升高有关。多因素分析显示预测肠道BD患者贫血的因素是较高的DAIBD(≥40;比值比,4.08;95%置信区间,1.21至13.71;p=0.023)。

结论

虽然贫血在肠道BD患者中很常见,但在日常实践中其临床重要性被忽视。中度至重度疾病活动是贫血的预测因素。

相似文献

1
Overlooked Management and Risk Factors for Anemia in Patients with Intestinal Behçet's Disease in Actual Clinical Practice.实际临床实践中肠道白塞病患者贫血的被忽视的管理与风险因素
Gut Liver. 2015 Nov 23;9(6):750-5. doi: 10.5009/gnl14193.
2
Incidence and risk factors for anemia among newly-diagnosed intestinal Behcet's disease patients.初诊肠型贝赫切特病患者贫血的发生率及相关危险因素。
J Natl Med Assoc. 2019 Aug;111(4):407-412. doi: 10.1016/j.jnma.2019.01.010. Epub 2019 Feb 23.
3
Expression of a soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) correlates with clinical disease activity in intestinal Behcet's disease.可溶性髓系细胞触发受体-1(sTREM-1)的表达与肠型贝赫切特病的临床疾病活动相关。
Inflamm Bowel Dis. 2011 Oct;17(10):2130-7. doi: 10.1002/ibd.21600. Epub 2011 Jan 6.
4
Risk Factors and Outcomes of Emergency Room Visits in Intestinal Behçet's Disease.肠白塞病患者急诊就诊的风险因素和结局。
Digestion. 2017 Nov;96(4):231-238. doi: 10.1159/000484084. Epub 2017 Nov 2.
5
Correlations between endoscopic and clinical disease activity indices in intestinal Behcet's disease.肠白塞病内镜与临床疾病活动指数的相关性。
World J Gastroenterol. 2012 Oct 28;18(40):5771-8. doi: 10.3748/wjg.v18.i40.5771.
6
Correlation between soluble triggering receptor expressed on myeloid cells-1 and endoscopic activity in intestinal Behçet's disease.肠道白塞病中髓样细胞表达的可溶性触发受体-1与内镜活动度的相关性
Yonsei Med J. 2014 Jul;55(4):960-6. doi: 10.3349/ymj.2014.55.4.960.
7
Development of a Novel Endoscopic Scoring System to Predict Relapse after Surgery in Intestinal Behçet's Disease.开发一种新的内镜评分系统预测肠白塞病手术后复发。
Gut Liver. 2018 Nov 15;12(6):674-681. doi: 10.5009/gnl17547.
8
Development, validation, and responsiveness of a novel disease activity index for intestinal Behçet's disease.一种新型肠道贝赫切特病疾病活动指数的制定、验证和反应性。
Inflamm Bowel Dis. 2011 Feb;17(2):605-13. doi: 10.1002/ibd.21313.
9
Serum levels of IgG antibodies against alpha-enolase are increased in patients with Behçet's disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates, and C-reactive protein.白塞病患者血清中抗α-烯醇化酶IgG抗体水平升高,且与口腔溃疡的严重程度、红细胞沉降率及C反应蛋白相关。
Clin Exp Rheumatol. 2017 Nov-Dec;35 Suppl 108(6):67-74. Epub 2017 Jul 6.
10
Serum anti-lysozyme is associated with disease activity of Behçet's disease.血清抗溶菌酶与白塞病的疾病活动相关。
Int J Rheum Dis. 2017 Feb;20(2):261-268. doi: 10.1111/1756-185X.12832. Epub 2016 Feb 18.

引用本文的文献

1
Incidence and risk factors of micronutrient deficiency in patients with IBD and intestinal Behçet's disease: folate, vitamin B12, 25-OH-vitamin D, and ferritin.炎症性肠病和肠型贝赫切特病患者微量营养素缺乏的发生率和危险因素:叶酸、维生素 B12、25-羟维生素 D 和铁蛋白。
BMC Gastroenterol. 2021 Jan 21;21(1):32. doi: 10.1186/s12876-021-01609-8.
2
Correlation of clinical signs and symptoms of Behçet's disease with mean platelet volume (MPV) and red cell distribution width (RDW).探讨白塞病的临床症状和体征与血小板平均体积(MPV)和红细胞分布宽度(RDW)的相关性。
Orphanet J Rare Dis. 2020 Oct 21;15(1):297. doi: 10.1186/s13023-020-01588-1.
3
Updated treatment strategies for intestinal Behçet's disease.肠道白塞病的更新治疗策略。
Korean J Intern Med. 2018 Jan;33(1):1-19. doi: 10.3904/kjim.2017.377. Epub 2017 Dec 8.
4
Risk factors and outcomes of acute lower gastrointestinal bleeding in intestinal Behçet's disease.肠道白塞病急性下消化道出血的危险因素及结局
Int J Colorectal Dis. 2017 May;32(5):745-751. doi: 10.1007/s00384-016-2728-x. Epub 2016 Dec 6.
5
The Efficiency of Intravenous Iron Therapy in Korean Inflammatory Bowel Disease Patients.静脉铁剂治疗对韩国炎症性肠病患者的疗效
Gut Liver. 2016 Jul 15;10(4):487-8. doi: 10.5009/gnl16205.
6
The Correlation of Serum IL-12B Expression With Disease Activity in Patients With Inflammatory Bowel Disease.炎症性肠病患者血清白细胞介素-12B表达与疾病活动度的相关性
Medicine (Baltimore). 2016 Jun;95(23):e3772. doi: 10.1097/MD.0000000000003772.

本文引用的文献

1
Radiation exposure from abdominal imaging studies in patients with intestinal Behçet disease.肠道白塞病患者腹部影像学检查的辐射暴露
Gut Liver. 2014 Jul;8(4):380-7. doi: 10.5009/gnl.2014.8.4.380. Epub 2013 Dec 24.
2
Association between red cell distribution width and disease activity in patients with inflammatory bowel disease.红细胞分布宽度与炎症性肠病患者疾病活动度的关系。
Dig Dis Sci. 2012 Apr;57(4):1033-8. doi: 10.1007/s10620-011-1978-2. Epub 2011 Dec 7.
3
Supplementation with oral vs. intravenous iron for anemia with IBD or gastrointestinal bleeding: is oral iron getting a bad rap?口服铁剂与静脉铁剂治疗 IBD 或胃肠道出血相关贫血:口服铁剂是否受到了不公正的指责?
Am J Gastroenterol. 2011 Nov;106(11):1872-9. doi: 10.1038/ajg.2011.232.
4
Development, validation, and responsiveness of a novel disease activity index for intestinal Behçet's disease.一种新型肠道贝赫切特病疾病活动指数的制定、验证和反应性。
Inflamm Bowel Dis. 2011 Feb;17(2):605-13. doi: 10.1002/ibd.21313.
5
Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatment.炎症性肠病中贫血的患病率和发病机制。抗肿瘤坏死因子-α治疗的影响。
Haematologica. 2010 Feb;95(2):199-205. doi: 10.3324/haematol.2009.009985. Epub 2009 Oct 8.
6
Red cell distribution width for assessment of activity of inflammatory bowel disease.用于评估炎症性肠病活动度的红细胞分布宽度
Dig Dis Sci. 2009 Apr;54(4):842-7. doi: 10.1007/s10620-008-0436-2. Epub 2008 Aug 21.
7
Behcet's disease associated with bone marrow failure in Korean patients: clinical characteristics and the association of intestinal ulceration and trisomy 8.韩国患者中与骨髓衰竭相关的白塞病:临床特征及肠道溃疡与8号染色体三体的关联
Rheumatology (Oxford). 2008 Aug;47(8):1228-30. doi: 10.1093/rheumatology/ken162. Epub 2008 Jun 11.
8
Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases.炎症性肠病中铁缺乏和贫血的诊断与管理指南。
Inflamm Bowel Dis. 2007 Dec;13(12):1545-53. doi: 10.1002/ibd.20285.
9
Systematic review: managing anaemia in Crohn's disease.系统评价:克罗恩病贫血的管理
Aliment Pharmacol Ther. 2006 Dec;24(11-12):1507-23. doi: 10.1111/j.1365-2036.2006.03146.x.
10
Myelodysplastic syndrome complicated with inflammatory intestinal ulcers: significance of trisomy 8.骨髓增生异常综合征合并炎症性肠溃疡:8号染色体三体的意义
Intern Med. 2006;45(22):1309-14. doi: 10.2169/internalmedicine.45.1718. Epub 2006 Dec 15.